Sergey Landa

Sergey Landa

Auto-generated profile, based on publicly available information

Sergey Landa

Petersburg Institute for Nuclear Physics n.a. B.P. Konstantinov of National Research Centre ‘Kurchatov Institute’; First Saint Petersburg State Medical University n.a. academician I.P. Pavlov

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Nanotechnologies in Russia
Verified
Journal Article
Closed access
PDF file
ASA. D. Slobodina
A. D. Slobodina
OBOlga Bolshakova
Olga Bolshakova
AKArtem Komissarov
Artem Komissarov
NSNina Surina
Nina Surina
SLS. B. Landa
S. B. Landa
SSSvetlana Sarantseva
Svetlana Sarantseva
An urgent task of modern medicine is the search for drugs that can stop or slow down the course of neurodegenerative diseases, in particular Alzheimer’s disease. The aim of this work was to determine the effect of fullerenol C60(OH)30 on the pathogenesis of Alzheimer’s disease in the Drosophila melanogaster model. The effect of fullerenol on the life expectancy, the level of geotaxis, learning and memory, and the levels of neurodegeneration and reactive oxygen species in the animal brain was studied. Based on the results, it can be assumed that fullerenol C60(OH)30 is a promising agent for the development of complex therapy for Alzheimer’s disease.

9 February 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TUTatiana Usenko
Tatiana Usenko
VMValentina Miroshnikova
Valentina Miroshnikova
ABAnastasia Bezrukova
Anastasia Bezrukova
KBKaterina Basharova
Katerina Basharova
SLSergey Landa
Sergey Landa
SPSofya Pchelina
Sofya Pchelina
Transcriptomic analysis conducted by us previously revealed upregulation of genes involved in low-density lipoprotein particle receptor (LDLR) activity pathway in lethal COVID-19 caused by SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). Last data suggested the possible role of extracellular vesicles in COVID-19 pathogenesis. The aim of the present study was to retrospectively evaluate parameters of cholesterol metabolism and newly identified EVs, exomeres, as possible predictors of fatal outcome of COVID-19 patients infected by the Alpha and the Delta variants of SARS-CoV-2 virus. Blood from 67 patients with severe COVID-19 were collected at the time of admission to the intensive care unit (ICU) and 7 days after admission to the ICU. After 30 days patients were divided into two subgroups according to outcome—34 non-survivors and 33 survivors. This study demonstrated that plasma low- and high-density lipoprotein cholesterol levels (LDL-C and HDL-C) were decreased in non-survivors compared to controls at the time of admission to the ICU. The conjoint fraction of exomeres and LDL particles measured by dynamic light scattering (DLS) was decreased in non-survivors infected by the Alpha and the Delta variants compared to survivors at the time of admission to the ICU. We first showed that reduction of exomeres fraction may be critical in fatal outcome of COVID-19.

29 March 2023 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
NVNikolay Verlov
Nikolay Verlov
LGL. S. Gulina
L. S. Gulina
VBV. S. Burdakov
V. S. Burdakov
IKI. S. Kulakov
I. S. Kulakov
SLS. B. Landa
S. B. Landa
ВЭВ. Л. Эмануэль
В. Л. Эмануэль
Introduction. Experimental model of intraperitoneal injection of sodium oxalate is one of the most promising and practical models of oxalate urolithiasis in rodents.Purpose of the study. To describe the urolithiasis progression in experimental animals with regard to the changes in the ion balance at various stages of pathology formation.Materials and methods. We treated male ICR (CD‑1) outbred laboratory mice with a single injection of sodium oxalate (NaOx) to perform nephrolithiasis modeling. The ionic composition of urine and blood serum in the control and experimental groups was examined by capillary electrophoresis. The presence of oxalate crystals in the urine sediment and histological data can assess the severity of the pathology.Results and conclusions. Increase of the level of Na and Ca ions and decrease of the level of K, NH4, Mg ions was observed in 4 hours and 24 hours after intraperitoneal injection of sodium oxalate, that can be regarded as a depression of tubular reabsorption and secretion.

10 November 2022 in medRxiv
Verified
Preprint
Open access
PDF file
TUTatiana Usenko
Tatiana Usenko
VMV.V. Miroshnikova
V.V. Miroshnikova
ABA.I. Bezrukova
A.I. Bezrukova
KBK.S. Basharova
K.S. Basharova
SLS.B. Landa
S.B. Landa
SPS.N. Pchelina
S.N. Pchelina
Transcriptomic analysis conducted by us previously revealed upregulation of genes involved in low-density lipoprotein particle receptor (LDLR) activity pathway in lethal COVID-19. Last data suggested the possible role of extracellular vesicles and exomeres in COVID-19 pathogenesis. The aim of the present study was to retrospectively evaluate parameters of cholesterol metabolism as possible predictors of fatal outcome of COVID-19. Blood from 39 patients with severe COVID-19 (the main cohort) were collected at the time of admission to the intensive care unit (ICU) (T1) and 7 days after admission to the ICU (T2). After 30 days patients were divided into two subgroups according to outcome-21 non-survivors and 18 survivors. 28 patients (13 non-survivors and 15 survivors) with severe COVID-19 were included as the replication cohort. The study demonstrated that plasma low-and high-density lipoprotein cholesterol levels (LDL-C and HDL-C) were decreased and CCL20/MIP3ɑ, IL-10, IL-15, IL-27 concentrations were increased in non-survivors compared to controls in T1. STAB1 gene expression was higher in non-survivors than in survivors (p=0.017) in T2. The conjoint fraction of exomeres and LDL particles measured by dynamic light scattering (DLS) was decreased in non-survivors com-pared to survivors in both the main and replication cohorts. We first showed that change of exomeres fraction may be critical in fatal outcome of COVID-19.